Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Name: Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

infections

meningococcal disease, infections, meningococcal

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180209
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.